YD Bio (NASDAQ:YDES) CEO Ethan Phd Shen Buys 3,100 Shares

YD Bio Limited (NASDAQ:YDES) CEO Ethan Phd Shen purchased 3,100 shares of YD Bio stock in a transaction that occurred on Wednesday, September 9th. The shares were bought at an average cost of $3.93 per share, with a total value of $12,183.00. Following the completion of the transaction, the chief executive officer directly owned 11,245,631 shares of the company’s stock, valued at approximately $44,195,329.83. The trade was a 0.03% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

YD Bio Stock Performance

Shares of YDES opened at $3.90 on Friday. The company’s fifty day simple moving average is $2.98 and its 200 day simple moving average is $4.53. YD Bio Limited has a 1-year low of $1.70 and a 1-year high of $25.00.

YD Bio (NASDAQ:YDES) last issued its earnings results on Tuesday, September 1st. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $0.42 million during the quarter.

Institutional Trading of YD Bio

A hedge fund recently raised its position in YD Bio stock. Geode Capital Management LLC lifted its position in shares of YD Bio Limited (NASDAQ:YDES) by 10.0% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 58,363 shares of the biotechnology company’s stock after buying an additional 5,292 shares during the quarter. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 as of its most recent SEC filing.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.